Functional amyloid formation within mammalian tissue.

Amyloid is a generally insoluble, fibrous cross-beta sheet protein aggregate. The process of amyloidogenesis is associated with a variety of neurodegenerative diseases including Alzheimer, Parkinson, and Huntington disease. We report the discovery of an unprecedented functional mammalian amyloid str...

Full description

Bibliographic Details
Main Authors: Douglas M Fowler, Atanas V Koulov, Christelle Alory-Jost, Michael S Marks, William E Balch, Jeffery W Kelly
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2006-01-01
Series:PLoS Biology
Online Access:https://doi.org/10.1371/journal.pbio.0040006
id doaj-753dcaaa8cb74e819c61f52270d806e1
record_format Article
spelling doaj-753dcaaa8cb74e819c61f52270d806e12021-07-02T16:29:12ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852006-01-0141e610.1371/journal.pbio.0040006Functional amyloid formation within mammalian tissue.Douglas M FowlerAtanas V KoulovChristelle Alory-JostMichael S MarksWilliam E BalchJeffery W KellyAmyloid is a generally insoluble, fibrous cross-beta sheet protein aggregate. The process of amyloidogenesis is associated with a variety of neurodegenerative diseases including Alzheimer, Parkinson, and Huntington disease. We report the discovery of an unprecedented functional mammalian amyloid structure generated by the protein Pmel17. This discovery demonstrates that amyloid is a fundamental nonpathological protein fold utilized by organisms from bacteria to humans. We have found that Pmel17 amyloid templates and accelerates the covalent polymerization of reactive small molecules into melanin-a critically important biopolymer that protects against a broad range of cytotoxic insults including UV and oxidative damage. Pmel17 amyloid also appears to play a role in mitigating the toxicity associated with melanin formation by sequestering and minimizing diffusion of highly reactive, toxic melanin precursors out of the melanosome. Intracellular Pmel17 amyloidogenesis is carefully orchestrated by the secretory pathway, utilizing membrane sequestration and proteolytic steps to protect the cell from amyloid and amyloidogenic intermediates that can be toxic. While functional and pathological amyloid share similar structural features, critical differences in packaging and kinetics of assembly enable the usage of Pmel17 amyloid for normal function. The discovery of native Pmel17 amyloid in mammals provides key insight into the molecular basis of both melanin formation and amyloid pathology, and demonstrates that native amyloid (amyloidin) may be an ancient, evolutionarily conserved protein quaternary structure underpinning diverse pathways contributing to normal cell and tissue physiology.https://doi.org/10.1371/journal.pbio.0040006
collection DOAJ
language English
format Article
sources DOAJ
author Douglas M Fowler
Atanas V Koulov
Christelle Alory-Jost
Michael S Marks
William E Balch
Jeffery W Kelly
spellingShingle Douglas M Fowler
Atanas V Koulov
Christelle Alory-Jost
Michael S Marks
William E Balch
Jeffery W Kelly
Functional amyloid formation within mammalian tissue.
PLoS Biology
author_facet Douglas M Fowler
Atanas V Koulov
Christelle Alory-Jost
Michael S Marks
William E Balch
Jeffery W Kelly
author_sort Douglas M Fowler
title Functional amyloid formation within mammalian tissue.
title_short Functional amyloid formation within mammalian tissue.
title_full Functional amyloid formation within mammalian tissue.
title_fullStr Functional amyloid formation within mammalian tissue.
title_full_unstemmed Functional amyloid formation within mammalian tissue.
title_sort functional amyloid formation within mammalian tissue.
publisher Public Library of Science (PLoS)
series PLoS Biology
issn 1544-9173
1545-7885
publishDate 2006-01-01
description Amyloid is a generally insoluble, fibrous cross-beta sheet protein aggregate. The process of amyloidogenesis is associated with a variety of neurodegenerative diseases including Alzheimer, Parkinson, and Huntington disease. We report the discovery of an unprecedented functional mammalian amyloid structure generated by the protein Pmel17. This discovery demonstrates that amyloid is a fundamental nonpathological protein fold utilized by organisms from bacteria to humans. We have found that Pmel17 amyloid templates and accelerates the covalent polymerization of reactive small molecules into melanin-a critically important biopolymer that protects against a broad range of cytotoxic insults including UV and oxidative damage. Pmel17 amyloid also appears to play a role in mitigating the toxicity associated with melanin formation by sequestering and minimizing diffusion of highly reactive, toxic melanin precursors out of the melanosome. Intracellular Pmel17 amyloidogenesis is carefully orchestrated by the secretory pathway, utilizing membrane sequestration and proteolytic steps to protect the cell from amyloid and amyloidogenic intermediates that can be toxic. While functional and pathological amyloid share similar structural features, critical differences in packaging and kinetics of assembly enable the usage of Pmel17 amyloid for normal function. The discovery of native Pmel17 amyloid in mammals provides key insight into the molecular basis of both melanin formation and amyloid pathology, and demonstrates that native amyloid (amyloidin) may be an ancient, evolutionarily conserved protein quaternary structure underpinning diverse pathways contributing to normal cell and tissue physiology.
url https://doi.org/10.1371/journal.pbio.0040006
work_keys_str_mv AT douglasmfowler functionalamyloidformationwithinmammaliantissue
AT atanasvkoulov functionalamyloidformationwithinmammaliantissue
AT christellealoryjost functionalamyloidformationwithinmammaliantissue
AT michaelsmarks functionalamyloidformationwithinmammaliantissue
AT williamebalch functionalamyloidformationwithinmammaliantissue
AT jefferywkelly functionalamyloidformationwithinmammaliantissue
_version_ 1721326475114708992